Login / Signup

Patients with B-cell lymphoma receiving anti-CD20 monoclonal antibody-containing chemotherapies and seroreactive patterns in response to COVID-19 vaccination.

Tohru InabaKeita OkumuraChika MaekuraAyako MuramatsuTsutomu KobayashiJunya KurodaYoko Nukui
Published in: International journal of hematology (2022)
Keyphrases
  • monoclonal antibody
  • coronavirus disease
  • sars cov
  • diffuse large b cell lymphoma
  • nk cells